HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Tridentate N-N-N chelating systems as potential antitumor agents].

Abstract
Tridentate chelating agents, as potential antitumor agents, were prepared by condensing 2-quinolylhydrazines, 2-pyridylhydrazine and 2-benzothiazolylhydrazine with pyridine-2-aldehyde, 6-methylpyridine-2-aldehyde, 2-acetylpyridine and 2-benzoylpyridine. All compounds were tested against Lymphocytic leukemia P388. The active pyridine-2-aldehyde-4-methyl-2-quinolylhydrazone [1-(4'-methyl-2'-quinolyl)-3-(2'-pyridyl)-1,2-diaza-2-propene] (I d) was also tested against other experimental tumors and proved inactive.
AuthorsC Pellerano, L Savini, P Massarelli
JournalIl Farmaco; edizione scientifica (Farmaco Sci) Vol. 40 Issue 9 Pg. 645-54 (Sep 1985) ISSN: 0430-0920 [Print] Italy
Vernacular TitleSistemi chelanti tridentati N-N-N quali potenziali agenti antitumorali.
PMID4076429 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Chelating Agents
  • Hydrazones
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, chemical synthesis)
  • Cell Line
  • Chelating Agents (administration & dosage, chemical synthesis)
  • Chemical Phenomena
  • Chemistry
  • Female
  • Hydrazones (pharmacology)
  • Leukemia P388 (drug therapy)
  • Male
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: